Emergent BioSolutions Inc [EBS]
$47.11 1.39 (3.04%)
Market Cap 2.42 Billion
Emergent BioSolutions Inc is a global biotechnology company that offers biopharmaceutical products to healthcare providers and governments. The company has two operating divisions: biodefense and biosciences. Its specialty biodefense division focuses on countermeasures that address public health threats. The U.S. government is the primary purchaser of these products and often provides substantial funding for their development. Emergent's biosciences business is primarily focused on hematology and oncology therapeutics, with a secondary focus on transplantation, infectious disease, and autoimmunity.
EPS -0.51 P/E Ratio 35.92
Previous Earnings Thu, Feb 21, 2019
Pay Date --
|Symbol||Price||Day %||YTD %|
This list of trending stocks may change throughout the trading day.